Media coverage
2
Media coverage
Title -Janssen Pharmaceutical - U.S. FDA Approves TALVEY, a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Media name/outlet M2 PressWIRE Country/Territory United States Date 11/08/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68XB-SN31-JD3Y-Y1YR-00000-00 Persons Ajai Chari Title -Janssen Pharmaceutical - U.S. FDA Approves TALVEY, a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Media name/outlet ENP Newswire Country/Territory United Kingdom Date 11/08/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68XB-SN31-JD3Y-Y1VD-00000-00 Persons Ajai Chari